We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 615

Attorney General’s office may weigh in on constitutionality of IPRs involving Pre-AIA patents
  • Pepper Hamilton LLP
  • USA
  • September 19 2018

The 2011 America Invents Act (AIA) provided a variety of new ways to administratively challenge patents, including the now widely used inter partes


PTAB Finds Recycled Art and Advanced State of Parallel District Proceeding Warrant Denial of IPR Trial
  • Mintz
  • USA
  • September 17 2018

Last week the Patent Trial and Appeal Board (“PTAB”) provided yet another arrow in the patent owner’s quiver for defending against institution of IPRs


Magistrate Judge Pollak Recommends Granting Motion to Stay Pending Inter Partes Review
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • September 17 2018

On September 12, 2018, Magistrate Judge Cheryl Pollak issued a report recommending that defendants Quest USA Corp.'s and Isaac Srour's (collectively


RPX Requests en banc Review in Applications in Internet Time v. RPX
  • Mintz
  • USA
  • September 13 2018

On September 7, 2018, RPX Corporation (“RPX”) requested a rehearing en banc of the Federal Circuit’s July 2018 Applications in Internet Time, LLC v


The CRISPR Patent Dispute - No interference upheld by the US Court of Appeals
  • Davies Collison Cave
  • USA
  • September 13 2018

In a decision handed down on 10 September 2018, the US Court of Appeals for the Federal Circuit has unanimously upheld the decision of the Patent


PTAB Expands Equitable Considerations to Deny AIA Trial Petitions
  • Ropes & Gray LLP
  • USA
  • September 13 2018

As I have mentioned on a few CLE panels as of late, the recent changes to the Patent Trial & Appeal Board's (PTAB) Trial Practice Guide invite


Vestas Files New Challenge Against GE Wind Turbine Patent
  • Duane Morris LLP
  • USA
  • September 12 2018

After filing a first challenge against GE’s U.S. Patent No. 6,921, 985 in May, Vestas has filed a second challenge in August to expand its attack on


New Arguments in Momenta On Standing to Appeal IPR Loss Before Filing a Biosimilar Application
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • September 12 2018

In Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Co., No. 17-1694 (Fed. Cir. argued Dec. 5, 2017), BMS challenges Momenta’s standing to appeal


UC v. Broad Institute: No Interference-In-Fact in CRISPR Genome Editing Applications
  • Knobbe Martens
  • USA
  • September 12 2018

On September 10, 2018, the Federal Circuit decided Regents of the University of California v. Broad Institute, Inc., affirming the Patent Trial and


Pfizer Loses Out On Its Follow-On Petition Challenges to Genentech’s anti-HER2 Patents Because It Did Not Follow General Plastics Guidance
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • September 11 2018

Recently, Pfizer was denied institution of two follow-on inter partes review (IPR) petitions, IPR Nos. 2018-00330 and 2018-00331 (“the 2018